Medicamen Biotech Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
430.74 Cr.
|
P/BV
|
1.99
|
Book Value (Rs.)
|
159.80
|
52 Week High/Low (Rs.)
|
630/293
|
FV/ML
|
10/1
|
P/E(X)
|
60.60
|
Bookclosure
|
19/09/2025
|
EPS (Rs.)
|
5.24
|
Div Yield (%)
|
0.31
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 9.88 | 9.49 | 14.73 | 14.90 | 12.13 |
| | | | | |
Net CashFlow From Operating Activities | -7.19 | -6.74 | -6.29 | 4.11 | 12.77 |
Net Cash Used In Investing Activities | -1.89 | -5.56 | -5.88 | -8.47 | -17.81 |
Net Cash Used From Financing Activities | -1.94 | 6.31 | 29.13 | 4.30 | 5.84 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -11.02 | -5.99 | 16.95 | -0.07 | 0.80 |
Cash And Cash Equivalents Begin of Year | 14.77 | 20.78 | 3.82 | 3.89 | 3.09 |
Cash And Cash Equivalents End Of Year | 3.75 | 14.79 | 20.78 | 3.82 | 3.89 |